id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
42,,,,,,,,,,,,,,,2024-05-04T16:58:05+06:00,BSH - H12307356435,Right,Paclitaxel,2023-11-12,6.0,"Started NACT with ddEC from 04.07.2023 at India, C4 completed on 16.08.2023> Received
Cycle 5 @TMC on 30.08.2023 from India with Paclitaxel (330mg) + Trastuzumab (670mg- Loading dose)
@India > C6 continued at BSHL from 20.09.2023 with Trastuzumab only but developed chest discomfort
and breathlessness during Paclitaxel and Postponed. Further Chemotherapy was held due to poor EF.
Restarted ChT only C6 Paclitaxel 300mg today on 12.11.2023> Cycle 7 due on 03.12.2023 (Postponed and
sent for Surgery)",2024-02-20,,2024-03-18,,2024-02-20,,,Breast,39,Upper middle class,BSBSC-240000039,MST. AKHTARUN NESSA,1759254302,1960-01-01,Female,,,,,Dr Md Arifur Rahman,BSH,2.0,1st Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.4- Upper-outer quadrant of breast,Breast,Right,,,Progressed,Alive,PD,,,,,,,,,,,,,,,,,,,,,
